Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B

To investigate the reduction of cell viability in human hepatocellular carcinoma (HCC) cell lines induced by inhibition of nuclear factor kappa B (NF kappa B). HLE, SKHep1, and HepG2 were incubated and E3330 was used to compare the stimulation of some chemotherapeutic drugs with that of TNF family,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2005-10, Vol.11 (40), p.6258-6261
Hauptverfasser: Saitou, Yukiko, Shiraki, Katsuya, Yamanaka, Takenari, Miyashita, Kazumi, Inoue, Tomoko, Yamanaka, Yutaka, Yamaguchi, Yumi, Enokimura, Naoyuki, Yamamoto, Norihiko, Itou, Keiichi, Sugimoto, Kazushi, Nakano, Takeshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6261
container_issue 40
container_start_page 6258
container_title World journal of gastroenterology : WJG
container_volume 11
creator Saitou, Yukiko
Shiraki, Katsuya
Yamanaka, Takenari
Miyashita, Kazumi
Inoue, Tomoko
Yamanaka, Yutaka
Yamaguchi, Yumi
Enokimura, Naoyuki
Yamamoto, Norihiko
Itou, Keiichi
Sugimoto, Kazushi
Nakano, Takeshi
description To investigate the reduction of cell viability in human hepatocellular carcinoma (HCC) cell lines induced by inhibition of nuclear factor kappa B (NF kappa B). HLE, SKHep1, and HepG2 were incubated and E3330 was used to compare the stimulation of some chemotherapeutic drugs with that of TNF family, Fas ligand, TNF alpha and TNF-related apoptosis-inducing ligand (TRAIL) at the point of the reduction of cell viability by inhibiting NF kappa B. E3330 decreased NF kappa B levels in HLE cells stimulated by TNF and TRAIL. The cytotoxicity of the combination of TRAIL, TNF alpha, Fas ligand, and E3330 increased synergistically in a dose-dependent manner compared to either E3330 alone in all HCC cell lines by MTT assay. However, the combination of some chemotherapeutic drugs and E3330 did not decrease the cell viability. Inhibition of NF kappa B sensitizes human HCC cell lines to TNF-mediated apoptosis including TRAIL, and TRAIL-based tumor therapy might be a powerful potential therapeutic tool in the treatment of human HCC.
doi_str_mv 10.3748/wjg.v11.i40.6258
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>wjg200540004</wanfj_id><sourcerecordid>wjg200540004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-c1fb3237e630d8bc65e809e6ae09bd31a5d9e99b344d69337c87be6db1e82a0e3</originalsourceid><addsrcrecordid>eNpVUU1v1DAQtRCILoU7J-QD4pbt-CNfF6S2agGpopdytiaOs-slsYOdbLU_g3-Mwy5QLrY8896b8XuEvGWwFqWsLh53m_WesbWVsC54Xj0jK85ZnfFKwnOyYgBlVgtenpFXMe4AuBA5f0nOWCFZzXK-Ij8v581g3IST9Y76jk7z4AN1RgcfbaQd6im9Oxxsf8isa2dtWoqjH6ff_eZAb4QQQK2j23nAdJoRJ69N3889BqoxaOv8gHQp0d46E-neYiJsbWP_jP16S7_jOCK9ek1edNhH8-Z0n5NvtzcP15-zu_tPX64v7zItuZgyzbpGcFGaQkBbNbrITQW1KdBA3bSCYd7Wpq4bIWVb1EKUuiobU7QNMxVHMOKcfDzqjnMzmFYnEwL2agx2wHBQHq36v-PsVm38XknBIXmaBN4fBR7Rdeg2aufn4NLKKsXCAXIJADLBPpzmBP9jNnFSg42LF-iMn6MqaigFl3kCwhG4WB-D6f7uwkAtcS-6KsWtUtxqiTtR3j39wz_CKV_xC2epqkI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69073245</pqid></control><display><type>article</type><title>Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Saitou, Yukiko ; Shiraki, Katsuya ; Yamanaka, Takenari ; Miyashita, Kazumi ; Inoue, Tomoko ; Yamanaka, Yutaka ; Yamaguchi, Yumi ; Enokimura, Naoyuki ; Yamamoto, Norihiko ; Itou, Keiichi ; Sugimoto, Kazushi ; Nakano, Takeshi</creator><creatorcontrib>Saitou, Yukiko ; Shiraki, Katsuya ; Yamanaka, Takenari ; Miyashita, Kazumi ; Inoue, Tomoko ; Yamanaka, Yutaka ; Yamaguchi, Yumi ; Enokimura, Naoyuki ; Yamamoto, Norihiko ; Itou, Keiichi ; Sugimoto, Kazushi ; Nakano, Takeshi</creatorcontrib><description>To investigate the reduction of cell viability in human hepatocellular carcinoma (HCC) cell lines induced by inhibition of nuclear factor kappa B (NF kappa B). HLE, SKHep1, and HepG2 were incubated and E3330 was used to compare the stimulation of some chemotherapeutic drugs with that of TNF family, Fas ligand, TNF alpha and TNF-related apoptosis-inducing ligand (TRAIL) at the point of the reduction of cell viability by inhibiting NF kappa B. E3330 decreased NF kappa B levels in HLE cells stimulated by TNF and TRAIL. The cytotoxicity of the combination of TRAIL, TNF alpha, Fas ligand, and E3330 increased synergistically in a dose-dependent manner compared to either E3330 alone in all HCC cell lines by MTT assay. However, the combination of some chemotherapeutic drugs and E3330 did not decrease the cell viability. Inhibition of NF kappa B sensitizes human HCC cell lines to TNF-mediated apoptosis including TRAIL, and TRAIL-based tumor therapy might be a powerful potential therapeutic tool in the treatment of human HCC.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v11.i40.6258</identifier><identifier>PMID: 16419152</identifier><language>eng</language><publisher>United States: First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507,Japan</publisher><subject>Apoptosis - physiology ; Apoptosis Regulatory Proteins - metabolism ; Benzoquinones - pharmacology ; Carcinoma, Hepatocellular - metabolism ; Cell Line, Tumor ; Cell Proliferation ; Cell Survival ; Genes, Reporter ; Humans ; Liver Cancer ; Liver Neoplasms - metabolism ; Membrane Glycoproteins - metabolism ; NF-kappa B - antagonists &amp; inhibitors ; NF-kappa B - metabolism ; Propionates - pharmacology ; TNF-Related Apoptosis-Inducing Ligand ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>World journal of gastroenterology : WJG, 2005-10, Vol.11 (40), p.6258-6261</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2005 Baishideng Publishing Group Inc. All rights reserved. 2005</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-c1fb3237e630d8bc65e809e6ae09bd31a5d9e99b344d69337c87be6db1e82a0e3</citedby><cites>FETCH-LOGICAL-c423t-c1fb3237e630d8bc65e809e6ae09bd31a5d9e99b344d69337c87be6db1e82a0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/wjg/wjg.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320327/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320327/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16419152$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saitou, Yukiko</creatorcontrib><creatorcontrib>Shiraki, Katsuya</creatorcontrib><creatorcontrib>Yamanaka, Takenari</creatorcontrib><creatorcontrib>Miyashita, Kazumi</creatorcontrib><creatorcontrib>Inoue, Tomoko</creatorcontrib><creatorcontrib>Yamanaka, Yutaka</creatorcontrib><creatorcontrib>Yamaguchi, Yumi</creatorcontrib><creatorcontrib>Enokimura, Naoyuki</creatorcontrib><creatorcontrib>Yamamoto, Norihiko</creatorcontrib><creatorcontrib>Itou, Keiichi</creatorcontrib><creatorcontrib>Sugimoto, Kazushi</creatorcontrib><creatorcontrib>Nakano, Takeshi</creatorcontrib><title>Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>To investigate the reduction of cell viability in human hepatocellular carcinoma (HCC) cell lines induced by inhibition of nuclear factor kappa B (NF kappa B). HLE, SKHep1, and HepG2 were incubated and E3330 was used to compare the stimulation of some chemotherapeutic drugs with that of TNF family, Fas ligand, TNF alpha and TNF-related apoptosis-inducing ligand (TRAIL) at the point of the reduction of cell viability by inhibiting NF kappa B. E3330 decreased NF kappa B levels in HLE cells stimulated by TNF and TRAIL. The cytotoxicity of the combination of TRAIL, TNF alpha, Fas ligand, and E3330 increased synergistically in a dose-dependent manner compared to either E3330 alone in all HCC cell lines by MTT assay. However, the combination of some chemotherapeutic drugs and E3330 did not decrease the cell viability. Inhibition of NF kappa B sensitizes human HCC cell lines to TNF-mediated apoptosis including TRAIL, and TRAIL-based tumor therapy might be a powerful potential therapeutic tool in the treatment of human HCC.</description><subject>Apoptosis - physiology</subject><subject>Apoptosis Regulatory Proteins - metabolism</subject><subject>Benzoquinones - pharmacology</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cell Survival</subject><subject>Genes, Reporter</subject><subject>Humans</subject><subject>Liver Cancer</subject><subject>Liver Neoplasms - metabolism</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>NF-kappa B - metabolism</subject><subject>Propionates - pharmacology</subject><subject>TNF-Related Apoptosis-Inducing Ligand</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1v1DAQtRCILoU7J-QD4pbt-CNfF6S2agGpopdytiaOs-slsYOdbLU_g3-Mwy5QLrY8896b8XuEvGWwFqWsLh53m_WesbWVsC54Xj0jK85ZnfFKwnOyYgBlVgtenpFXMe4AuBA5f0nOWCFZzXK-Ij8v581g3IST9Y76jk7z4AN1RgcfbaQd6im9Oxxsf8isa2dtWoqjH6ff_eZAb4QQQK2j23nAdJoRJ69N3889BqoxaOv8gHQp0d46E-neYiJsbWP_jP16S7_jOCK9ek1edNhH8-Z0n5NvtzcP15-zu_tPX64v7zItuZgyzbpGcFGaQkBbNbrITQW1KdBA3bSCYd7Wpq4bIWVb1EKUuiobU7QNMxVHMOKcfDzqjnMzmFYnEwL2agx2wHBQHq36v-PsVm38XknBIXmaBN4fBR7Rdeg2aufn4NLKKsXCAXIJADLBPpzmBP9jNnFSg42LF-iMn6MqaigFl3kCwhG4WB-D6f7uwkAtcS-6KsWtUtxqiTtR3j39wz_CKV_xC2epqkI</recordid><startdate>20051028</startdate><enddate>20051028</enddate><creator>Saitou, Yukiko</creator><creator>Shiraki, Katsuya</creator><creator>Yamanaka, Takenari</creator><creator>Miyashita, Kazumi</creator><creator>Inoue, Tomoko</creator><creator>Yamanaka, Yutaka</creator><creator>Yamaguchi, Yumi</creator><creator>Enokimura, Naoyuki</creator><creator>Yamamoto, Norihiko</creator><creator>Itou, Keiichi</creator><creator>Sugimoto, Kazushi</creator><creator>Nakano, Takeshi</creator><general>First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507,Japan</general><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20051028</creationdate><title>Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B</title><author>Saitou, Yukiko ; Shiraki, Katsuya ; Yamanaka, Takenari ; Miyashita, Kazumi ; Inoue, Tomoko ; Yamanaka, Yutaka ; Yamaguchi, Yumi ; Enokimura, Naoyuki ; Yamamoto, Norihiko ; Itou, Keiichi ; Sugimoto, Kazushi ; Nakano, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-c1fb3237e630d8bc65e809e6ae09bd31a5d9e99b344d69337c87be6db1e82a0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Apoptosis - physiology</topic><topic>Apoptosis Regulatory Proteins - metabolism</topic><topic>Benzoquinones - pharmacology</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cell Survival</topic><topic>Genes, Reporter</topic><topic>Humans</topic><topic>Liver Cancer</topic><topic>Liver Neoplasms - metabolism</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>NF-kappa B - metabolism</topic><topic>Propionates - pharmacology</topic><topic>TNF-Related Apoptosis-Inducing Ligand</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Saitou, Yukiko</creatorcontrib><creatorcontrib>Shiraki, Katsuya</creatorcontrib><creatorcontrib>Yamanaka, Takenari</creatorcontrib><creatorcontrib>Miyashita, Kazumi</creatorcontrib><creatorcontrib>Inoue, Tomoko</creatorcontrib><creatorcontrib>Yamanaka, Yutaka</creatorcontrib><creatorcontrib>Yamaguchi, Yumi</creatorcontrib><creatorcontrib>Enokimura, Naoyuki</creatorcontrib><creatorcontrib>Yamamoto, Norihiko</creatorcontrib><creatorcontrib>Itou, Keiichi</creatorcontrib><creatorcontrib>Sugimoto, Kazushi</creatorcontrib><creatorcontrib>Nakano, Takeshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saitou, Yukiko</au><au>Shiraki, Katsuya</au><au>Yamanaka, Takenari</au><au>Miyashita, Kazumi</au><au>Inoue, Tomoko</au><au>Yamanaka, Yutaka</au><au>Yamaguchi, Yumi</au><au>Enokimura, Naoyuki</au><au>Yamamoto, Norihiko</au><au>Itou, Keiichi</au><au>Sugimoto, Kazushi</au><au>Nakano, Takeshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2005-10-28</date><risdate>2005</risdate><volume>11</volume><issue>40</issue><spage>6258</spage><epage>6261</epage><pages>6258-6261</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>To investigate the reduction of cell viability in human hepatocellular carcinoma (HCC) cell lines induced by inhibition of nuclear factor kappa B (NF kappa B). HLE, SKHep1, and HepG2 were incubated and E3330 was used to compare the stimulation of some chemotherapeutic drugs with that of TNF family, Fas ligand, TNF alpha and TNF-related apoptosis-inducing ligand (TRAIL) at the point of the reduction of cell viability by inhibiting NF kappa B. E3330 decreased NF kappa B levels in HLE cells stimulated by TNF and TRAIL. The cytotoxicity of the combination of TRAIL, TNF alpha, Fas ligand, and E3330 increased synergistically in a dose-dependent manner compared to either E3330 alone in all HCC cell lines by MTT assay. However, the combination of some chemotherapeutic drugs and E3330 did not decrease the cell viability. Inhibition of NF kappa B sensitizes human HCC cell lines to TNF-mediated apoptosis including TRAIL, and TRAIL-based tumor therapy might be a powerful potential therapeutic tool in the treatment of human HCC.</abstract><cop>United States</cop><pub>First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507,Japan</pub><pmid>16419152</pmid><doi>10.3748/wjg.v11.i40.6258</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2005-10, Vol.11 (40), p.6258-6261
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320327
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Apoptosis - physiology
Apoptosis Regulatory Proteins - metabolism
Benzoquinones - pharmacology
Carcinoma, Hepatocellular - metabolism
Cell Line, Tumor
Cell Proliferation
Cell Survival
Genes, Reporter
Humans
Liver Cancer
Liver Neoplasms - metabolism
Membrane Glycoproteins - metabolism
NF-kappa B - antagonists & inhibitors
NF-kappa B - metabolism
Propionates - pharmacology
TNF-Related Apoptosis-Inducing Ligand
Tumor Necrosis Factor-alpha - metabolism
title Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T09%3A18%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Augmentation%20of%20tumor%20necrosis%20factor%20family-induced%20apoptosis%20by%20E3330%20in%20human%20hepatocellular%20carcinoma%20cell%20lines%20via%20inhibition%20of%20NF%20kappa%20B&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Saitou,%20Yukiko&rft.date=2005-10-28&rft.volume=11&rft.issue=40&rft.spage=6258&rft.epage=6261&rft.pages=6258-6261&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v11.i40.6258&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200540004%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69073245&rft_id=info:pmid/16419152&rft_wanfj_id=wjg200540004&rfr_iscdi=true